US Declares Monkeypox a Public Health Emergency; Ups Vaccine Supply
By

By
The US government has declared the spread of monkeypox virus in the US a public health emergency and has taken action to increase the supply of monkeypox vaccines in the…

Catalent To Acquire Metrics Contract Services for $475 M
By

By
Catalent has agreed to acquire Metrics Contract Services, a Greenville, North Carolina-based CDMO of oral solid dosage products, including high-potency products, for $475 million. Metrics, part of Mayne Pharma, an…

Pfizer To Acquire Global Blood Therapeutics for $5.4 Bn
By

By
Pfizer has agreed to acquire Global Blood Therapeutics (GBT), a San Francisco, California-based bio/pharmaceutical company focused on sickle cell-disease, for $5.4 billion, including debt and net of cash acquired. GBT’s…

AstraZeneca Completes $1.3-Bn Acquisition of TeneoTwo
By

By
AstraZeneca has completed its acquisition of TeneoTwo, a bio/pharmaceutical company, in a deal worth up to $1.3 billion ($100 million upfront, up to $805 million in additional contingent R&D-related milestone…

Supplier News: Sartorius, MilliporeSigma, Porton & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Sartorius, MilliporeSigma, Porton, West Pharmaceutical Services, CoreRx, Aptar Pharma, Datwyler, UPS Healthcare, Albumedix, Bomi, Latch Medical, and Pharmaxis.  Highlights below. Biologics Manufacturing*…

Mfg News: FDA, Merck & Co., Assure Infusions & More
By

By
A roundup of manufacturing news from FDA, Merck & Co., Assure Infusions, and SmartLabs.  Highlights below. * FDA Reports Nitrosamine Impurity in Diabetes Drug Sitagliptin* Assure Infusions Building IV Fluids…

Partnering News: AbbVie, Sanofi, BioNTech & More
By

By
A roundup of bio/pharmaceutical partnering news from AbbVie/Sosei, Sanofi/Innovent, and BioNTech/Genmab. * AbbVie, Sosei in $1.2-Bn Small-Molecule Neuroscience Drug Pact* Sanofi, Innovent in $455-M Cancer-Drug Pact in China* BioNTech, Genmab…

COVID News: Moderna and Lilly
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Moderna and Eli Lilly and Company. Highlights below. Manufacturing and supply of COVID-19 vaccines and drugs* EU To Buy More Doses of…

European Medicines Agency Issues Response Plan for Monkeypox
By

By
The European Medicines Agency (EMA) has initiated a series of actions to respond to the monkeypox outbreak, which was declared a Public Health Emergency of International Concern by the World Health…

Moderna, US Gov’t in $1.74-Bn Supply Pact for COVID-19 Omicron Vaccine Boosters
By

By
Moderna and the US government have entered into a supply pact, worth up to $1.74 billion, under which the US has secured 66 million doses of a Moderna COVID-19 bivalent…